Article information
Presentamos el caso de una recidiva de toxicidad pulmonar por amiodarona 4 meses después de la suspensión del fármaco y mientras seguía tratamiento con corticoides. Se sugieren como posibles causas la persistencia de niveles sanguíneos elevados de amiodarona y el rápido descenso de la dosis de corticoides.
Palabras clave:
Amiodarona
Toxicidad pulmonar
We present a case of recidivation in amiodarone-induced pulmonary toxicity 4 months after suspension of the drug, while treatment with corticoids was underway. Possible causes suggested are the persistence of high blood levels of amiodarone and the rapid decrease of corticoid dose.
Key words:
Amiodarone
Pulmonary toxicity
Full text is only aviable in PDF
Bibliografía
[1.]
J.W. Mason.
Drug therapy: Amiodarone.
N Engl J Med, 316 (1987), pp. 455-466
[2.]
J. Roca, M. Heras, R. Rodríguez-Roisin, J. Magriñá, A. Xaubet, G. Sanz.
Pulmonary complications after long term amiodarone treatment.
Thorax, 47 (1992), pp. 372-376
[3.]
J.I. Kennedy.
Clinical aspects of amiodarone pulmonary toxicity.
Clinics in Chest Medicine, 11 (1990), pp. 119-129
[4.]
C. Zaher, A. Hamer, T. Peter, W. Mandel.
Low-dose steroid therapy for prophylaxis of amiodarone-induced pulmonary infiltrates.
N Engl J Med, 308 (1983), pp. 779
[5.]
J. Joelson, J. Kluger, S. Cole, M. Conway.
Possible recurrence of amiodarone pulmonary toxicity following corticosteroids therapy.
Chest, 85 (1984), pp. 284-286
[6.]
F. Manresa, J. Dorca, B. Rodríguez-Sanchón, P. Romero.
Recurrent form of Amiodarone-induced pneumonitis (carta).
Chest, 86 (1984), pp. 944
[7.]
O. Parra, J. Ruiz, I. Ojanguren, J.J. Navas, J. Morera.
Amiodarone toxicity: recurrence of interstitial pneumonitis after withdrawal of the drug.
Eur Respir J, 2 (1989), pp. 905-907
[8.]
R.D. Wilson, C.F. Clarkson, M.L. Lingmann.
Amiodarone-induced pulmonary inflamation. Correlation with drug dose and lung levels of drug, metabolite, and phospholipid.
Am Rev Respir Dis, 143 (1991), pp. 1.110-1.114
[9.]
P.J. Kudenchuck, D.J. Pierson, H.L. Green, E.L. Graham, G.K. Sears, G.B. Trobaugh.
Prospective evaluation of amiodarone pulmonary toxicity.
Chest, 86 (1984), pp. 541-548
[10.]
J.I. Kennedy, J.L. Myers, V.J. Plumb, J.D. Fulmer.
Amiodarone pulmonary toxicity: Clinical, radiologic and pathologic correlations.
Arch Intern Med, 147 (1987), pp. 50-55
[11.]
H.H. Rotmensch, B. Belhassen, B.N. Swanson, D. Shoshani, S. Spielman, A.J. Greenspon, et al.
Steady-state serum amiodarone concentrations: Relationships with antiarrhytmic efficacy and toxicity.
Ann Intern Med, 101 (1984), pp. 462-469
[12.]
W.J. Martin, E.C. Rosenow.
Amiodarone pulmonary toxicity. Recognition and pathogenesis (part I).
Chest, 93 (1988), pp. 1.0671.075
Copyright © 1995. Sociedad Española de Neumología y Cirugía Torácica
